Home>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Avibactam (sodium salt)

Avibactam (sodium salt) Sale

(Synonyms: 阿维巴坦钠; NXL-104) 目录号 : GC42883

Avibactam (sodium salt)(NXL104, AVE1330A)是一种共价且可逆的非β-内酰胺类β-内酰胺酶抑制剂,有效抑制β-内酰胺酶TEM-1和CTX-M-15,IC50值分别为8 nM和5 nM。Avibactam对Ambler A类和C类β-内酰胺酶具有活性,并对某些Ambler D类酶也具有一定的活性。

Avibactam (sodium salt) Chemical Structure

Cas No.:1192491-61-4

规格 价格 库存 购买数量
2mg
¥350.00
现货
5mg
¥455.00
现货
10mM (in 1mL DMSO)
¥553.00
现货
10mg
¥665.00
现货
50mg
¥1,540.00
现货
100mg
¥2,310.00
现货
200mg
¥3,500.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

101

客户使用产品发表文献 1

Description

Avibactam (sodium salt) (NXL104, AVE1330A) is a covalent, reversible inhibitor of non-β-lactam β-lactamases. It effectively inhibits β-lactamase TEM-1 and CTX-M-15 with IC50 values of 8 nM and 5 nM, respectively. Avibactam is active against Ambler class A and C β-lactamases and also shows activity against certain Ambler class D enzymes. The mechanism of action of Avibactam is the formation of stable, irreversible covalent bonds at the active site of class A or class C beta-lactamases, resulting in permanent inactivation of the enzyme[1-3].

Avibactam (sodium salt) at a fixed concentration of 4 μg/ml dramatically improves the activities of cephalosporins against Enterobacteriaceae resistant to these agents by means of ESBL and AmpC β-lactamases[4-5].

Avibactam (sodium salt) and ceftazidime had bactericidal effects in infected with ceftazidime resistant Pseudomonas aeruginosa mice[6]. The addition of the beta-lactamase inhibitor avibactam (2-256 mg/kg; s.c; twice a day for five days) to ceftazidime restored the efficacy of ceftazidime in a mouse model of acute fatal septicemia in mice[7].

References:
[1]. Ehmann DE, Jahić H, et,al. Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor. Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11663-8. doi: 10.1073/pnas.1205073109. Epub 2012 Jul 2. PMID: 22753474; PMCID: PMC3406822.
[2]. Bhattacharya S, Bonnet A, et,al. inventors; Novexel SA and Forest laboratories holdings, assignees. Polymorphic and pseudopolymorphic forms of a pharmaceutical compound. International patent WO 042560 A2. 2011 April 14.
[3]. Stachyra T, Péchereau MC, et,al. Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor. Antimicrob Agents Chemother. 2010 Dec;54(12):5132-8. doi: 10.1128/AAC.00568-10. Epub 2010 Oct 4. PMID: 20921316; PMCID: PMC2981269.
[4]. Lagacé-Wiens PR, Tailor F, et,al. Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamases. Antimicrob Agents Chemother. 2011 May;55(5):2434-7. doi: 10.1128/AAC.01722-10. Epub 2011 Feb 28. PMID: 21357295; PMCID: PMC3088241.
[5]. Sader HS, Castanheira M, et,al. Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012. Antimicrob Agents Chemother. 2014;58(3):1684-92. doi: 10.1128/AAC.02429-13. Epub 2013 Dec 30. PMID: 24379201; PMCID: PMC3957905.
[6]. Berkhout J, Melchers MJ, et,al. Pharmacokinetics and penetration of ceftazidime and avibactam into epithelial lining fluid in thigh- and lung-infected mice. Antimicrob Agents Chemother. 2015 Apr;59(4):2299-304. doi: 10.1128/AAC.04627-14. Epub 2015 Feb 2. PMID: 25645843; PMCID: PMC4356781.
[7]. Endimiani A, Hujer KM, et,al. Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2011 Jan;55(1):82-5. doi: 10.1128/AAC.01198-10. Epub 2010 Nov 1. PMID: 21041503; PMCID: PMC3019638.

Avibactam (sodium salt)(NXL104, AVE1330A)是一种共价且可逆的非β-内酰胺类β-内酰胺酶抑制剂,有效抑制β-内酰胺酶TEM-1和CTX-M-15,IC50值分别为8 nM和5 nM。Avibactam对Ambler A类和C类β-内酰胺酶具有活性,并对某些Ambler D类酶也具有一定的活性。Avibactam的作用机制是在A类或C类β-内酰胺酶的活性位点形成稳定的、不可逆的共价键,导致酶永久失活[1-3]

固定浓度4 μg/ml的Avibactam可通过ESBL和AmpC β-内酰胺酶显著提高头孢菌素对耐药肠杆菌科细菌的活性[4-5]。Avibactam和ceftazidime对耐ceftazidime的铜绿假单胞菌感染小鼠有杀菌作用[6]。在小鼠急性致死性败血症小鼠模型中,加入ceftazidime (2-256 mg/kg; s.c; twice a day for five days)可恢复ceftazidime的疗效[7]

实验参考方法

Cell experiment [1]:

Cell lines

K. pneumonia (ESBL-producing)

Preparation Method

The bactericidal activity of cefepime in vitro with or without avibactam at 4 μg/ml was determined by broth microdilution method.

Reaction Conditions

4 μg/ml

Applications

Avibactam significantly increased the activity of cefepime against ESBL-producing strains, restoring 100% susceptibility to ESBL-producing organism.
Animal experiment [2]:

Animal models

CD-1 mice

Preparation Method

Mice were infected by the intraperitoneal injection of the KPC-producing K. pneumoniae strain resulting in the death of untreated controls within 24 to 48 h.Thirty minutes postinfection, a single subcutaneous dose of ceftazidime with and without avibactam was initiated, and the survival ratio was monitored for 5 days twice a day.

Dosage form

2-256 mg/kg; s.c; twice a day for five days

Applications

The addition of avibactam significantly reduced the amount of ceftazidime (CAZ) required to treat systemic infections in mice.

References:
[1]. Lagacé-Wiens PR, Tailor F,et,al. Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamases. Antimicrob Agents Chemother. 2011 May;55(5):2434-7. doi: 10.1128/AAC.01722-10. Epub 2011 Feb 28. PMID: 21357295; PMCID: PMC3088241.
[2].Endimiani A, Hujer KM, et,al. Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2011 Jan;55(1):82-5. doi: 10.1128/AAC.01198-10. Epub 2010 Nov 1. PMID: 21041503; PMCID: PMC3019638.

化学性质

Cas No. 1192491-61-4 SDF
别名 阿维巴坦钠; NXL-104
化学名 sulfuric acid, mono[(1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl] ester, monosodium salt
Canonical SMILES NC([C@H]1[N@@](C2)C(N(OS([O-])(=O)=O)[C@@H]2CC1)=O)=O.[Na+]
分子式 C7H10N3O6S•Na 分子量 287.2
溶解度 5mg/mL in DMSO, or in DMF 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 3.4819 mL 17.4095 mL 34.8189 mL
5 mM 0.6964 mL 3.4819 mL 6.9638 mL
10 mM 0.3482 mL 1.7409 mL 3.4819 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

产品文档

Quality Control & SDS

View current batch: